7 min read·Nov 11, 2026
$ABCL vs.$RXRX: The $800M Hot Flash vs. The Phenomics Paradox
In the era where biology meets computation, two very different approaches to industrialising drug discovery: AbCellera ($ABCL) and Recursion Pharmaceuticals ($RXRX). Both were born from the ambition